IL6 and lung adenocarcinoma: The results showed that metformin treatment could significantly reduce IL-6-induced STAT3 phosphorylation in A549, HCC827 and HCC827-pSB388 lung adenocarcinoma cells in a dose-dependent manner (Fig. 6A-B).